Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Acromegaly

Acromegaly is a syndrome that results when the pituitary gland produces excess growth hormone after epiphyseal plate closure. A number of disorders may be affecting the pituitary to create this circumstance, although most commonly it involves a GH producing tumor derived from a distinct type of cells and called pituitary adenoma.Acromegaly most commonly affects adults in their early twenties, and can result in severe disfigurement, serious complicating conditions, and premature death if unchecked. Because of its insidious pathogenesis and slow progression, the disease is hard to diagnose in the early stages and is frequently missed for many years, when changes in external features, especially of the face, become noticeable.Acromegaly is often also associated with gigantism. (From the Wikpedia article Acromegaly.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Acromegaly:

Pubmed Logo
Pegvisomant: current and potential novel therapeutic applications.
BACKGROUND: Pegvisomant is a genetically engineered molecule, which...
18th November, 2009
University of Cambridge, Department of Paediatrics, Cambridge, UK. Expert Opin Biol Ther. 2009 Dec;9(12):1553-63.
DOI Direct Link
Acromegaly pathogenesis and treatment.
Dysregulated growth hormone (GH) hypersecretion is usually caused by a...
18th November, 2009
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, J Clin Invest. 2009 Nov;119(11):3189-202. doi: 10.1172/JCI39375. Epub 2009
DOI Direct Link
Endovascular obliteration of an intracranial pseudoaneurysm: the utility of Onyx.
Pseudoaneurysms are rare lesions with a multitude of causes, including...
18th November, 2009
Department of Neurological Surgery, University of Virginia Health System, J Neurosurg Pediatr. 2009 Nov;4(5):445-8.
DOI Direct Link
Aftercare in patients with Cushing's disease and acromegaly: is there room for improvement?
PURPOSE: Evaluation of aftercare, medical therapy and remission rate for...
17th November, 2009
Department of Neurosurgery, University of Tuebingen, Hoppe-Seyler-Strasse Acta Neurochir (Wien). 2009 Nov 13.
DOI Direct Link
Increased plasma endothelin level as an endothelial marker of cardiovascular risk in patients with active acromegaly: A comparison with plasma homocysteine.
The aim of the present study was to evaluate the plasma endothelin-1...
13th November, 2009
Clinical Center of Endocrinology, Medical University, Sofia, Bulgaria. Methods Find Exp Clin Pharmacol. 2009 Sep;31(7):457-61.
DOI Direct Link

View more research publications.

Press Releases About Acromegaly:

BioPortfolio Logo
Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends 10th November, 2009 Reportlinker
-- Outlook for the injectable drug delivery technology Who should buy this report? -- Stakeholders in the injectable drug delivery market -- Companies interested in understanding

BioNews Results for Acromegaly:

RSS Logo
BioPortfolio Logo
Higher hydrocortisone dose may be associated with increased mortality in acromegaly
Endocrine Today:  Nov 12 2009 4:42PM Matching: acromegaly
Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends
Freshnews.com:  Nov 10 2009 4:54PM Matching: acromegaly

Acromegaly Clinical Trials:

Clinical Trials Logo
Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance

Acromegaly Patents:

USPTO Logo
US Patent No.Title
7534595 Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
7558778 Semantic exploration and discovery
7560100 Mixtures of polypeptides, compositions containing and processes for preparing same, for treating neurodegenerative diseases
7560101 Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A
7560102 Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease

View more patents.

Companies working in the area of Acromegaly from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Tercica

Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to...
www.tercica.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Acromegaly scientists - we have details of around 722 individuals working on Acromegaly .


This page has been viewed 498 times
Recent Search Terms used to find this page: acromegaly 2009 pdf | can you be born with acromegaly | acromegaly minneapolis | disfigurement in acromegaly | lanreotide feline acromegaly | Who discovered Acromegaly | acromegaly feline profile | clinical trials in acromegaly | how to diagnose acromegaly | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Acromegaly across BioPortfolio, or for Acromegaly Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.